Overview

To Evaluate the Safety, Tolerability and Analgesic Efficacy of SAF312 in Postoperative Dental Pain Patients

Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
The study will assess the analgesic efficacy and safety and tolerability of a single oral dose of SAF312 in postoperative dental pain patients after 3rd molar extraction.
Phase:
Phase 2
Details
Lead Sponsor:
Novartis
Treatments:
Ibuprofen